NCT00319605已完成不适用
Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam (Keppra®) (SOLUCION Study)
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- UCB Pharma
- 入组人数
- 600
研究概览
简要总结
Phase IV, observational, post-authorization, cross sectional, open-label, multicenter study to evaluate the acceptability of oral solution of levetiracetam in patients with partial epilepsy as assessed by a questionnaire.
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients 16 years old or older diagnosed with partial epilepsy with or without generalization receiving levetiracetam oral solution for at least 28 days before the study
排除标准
- •Patients with disturbances of the sense of taste and smell that can interfere with the assessment of the parameters of the study
研究者
相似试验
已完成
4 期
A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE TerritoriesHIV InfectionsNCT05514509ViiV Healthcare370
已完成
4 期
A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic FibrosisCystic FibrosisNCT01712334Genentech, Inc.99
已完成
4 期
A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With AsthmaAsthmaNCT02233803GlaxoSmithKline239
已完成
4 期
Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive KeratectomyPhotorefractive KeratectomyCorneal De-epithelializationNCT04704518Laboratorios Sophia S.A de C.V.96
已完成
3 期
Fosamprenavir Versus Other Protease InhibitorsInfection, Human Immunodeficiency Virus INCT00094523ViiV Healthcare314